Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.71737 | 30 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.69157 | 31 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.69805 | 31 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.63576 | 30 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.63343 | 30 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.02858 | 41 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.84409 | 35 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.67361 | 30 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.65469 | 30 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.67876 | 30 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.68131 | 30 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.66143 | 30 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.68592 | 30 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.68237 | 30 |